Regenity Biosciences

Regenity Biosciences is a leader in regenerative medicine, focusing on bioresorbable technologies for tissue and bone repair in medical and dental applications. Founded in 1997 as Collagen Matrix, Inc., the company rebranded after acquiring Polyganics, enhancing its expertise in synthetic polymers. Headquartered in Paramus, New Jersey, Regenity operates additional facilities in Oakland and Allendale, New Jersey, and Groningen, Netherlands, employing over 275 people and serving clients in 86 countries. The company develops and manufactures a wide range of bioresorbable implants and devices, with over 71 product lines targeting areas such as dental, spine, orthopedic, neurosurgery, ENT, nerve repair, and sports medicine. Their offerings include collagen-based solutions, synthetic polymers, and bioceramics, designed to support natural tissue regeneration. Regenity also provides comprehensive contract development and manufacturing services, including raw material supply, product development, and regulatory support, ensuring a streamlined process from concept to commercialization.